UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 160

Sortiert nach

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

Haematologica (Roma), 2010-04, Vol.95 (4), p.557-566

2010

Link zum Volltext

Verfügbarkeit prüfen

Prominent role of TGF-β1 in thrombopoietin-induced myelofibrosis in mice

Blood, 2002-11, Vol.100 (10), p.3495-3503

2002

Link zum Volltext

Verfügbarkeit prüfen

Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor

Blood, 2010-02, Vol.115 (5), p.1037-1048

2010

Link zum Volltext

Verfügbarkeit prüfen

Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis

Blood, 2007-11, Vol.110 (10), p.3735-3743

2007

Link zum Volltext

Verfügbarkeit prüfen

Ex Vivo Characterization of Multiepitopic Tumor-Specific CD8 T Cells in Patients with Chronic Myeloid Leukemia: Implications for Vaccine Development and Adoptive Cellular Immunotherapy

The Journal of immunology (1950), 2005-06, Vol.174 (12), p.8210-8218

2005

Link zum Volltext

Verfügbarkeit prüfen

Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia

The European respiratory journal, 2018-12, Vol.52 (6), p.1801482

2018

Link zum Volltext

Verfügbarkeit prüfen

Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs

Blood advances, 2022-09, Vol.6 (17), p.5171-5183

2022

Link zum Volltext

Verfügbarkeit prüfen

Calcific tendinopathy: an unexpected side effect of tyrosine kinase inhibitor?

Leukemia & lymphoma, 2022-12, Vol.63 (13), p.3175-3180

2022

Link zum Volltext

Verfügbarkeit prüfen

Insights into the Potential Mechanisms of JAK2V617F Somatic Mutation Contributing Distinct Phenotypes in Myeloproliferative Neoplasms

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1013

2022

Link zum Volltext

Verfügbarkeit prüfen

Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia

Cancer, 2017-11, Vol.123 (22), p.4403-4410

2017

Link zum Volltext

Verfügbarkeit prüfen

Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO

Blood, 2003-04, Vol.101 (8), p.2983-2989

2003

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of Thrombocytopenia During Septic Shock: A Multiplex Cluster Analysis of Endogenous Sepsis Mediators

Shock (Augusta, Ga.), 2018-06, Vol.49 (6), p.641-648

2018

Link zum Volltext

Verfügbarkeit prüfen

From 1 to 2 mutated JAK2: the road from ET to PV

Blood, 2006-10, Vol.108 (7), p.2140-2141

2006

Link zum Volltext

Verfügbarkeit prüfen

JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders

Blood, 2008-08, Vol.112 (4), p.1402-1412

2008

Link zum Volltext

Verfügbarkeit prüfen

High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice

Blood, 1997-12, Vol.90 (11), p.4369-4383

1997

Link zum Volltext

Verfügbarkeit prüfen

Retinoid-induced activation of NF-κB in APL cells is not essential for granulocytic differentiation, but prolongs the life span of mature cells

Oncogene, 2005-11, Vol.24 (48), p.7145-7155

2005

Link zum Volltext

Verfügbarkeit prüfen

Role for the nuclear factor κB pathway in transforming growth factor-β1 production in idiopathic myelofibrosis : Possible relationship with FK506 binding protein 51 overexpression

Cancer research (Chicago, Ill.), 2005-04, Vol.65 (8), p.3281-3289

2005

Link zum Volltext

Verfügbarkeit prüfen

miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets

Blood, 2010-07, Vol.116 (3), p.437-445

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID)

Leukemia, 2023-08, Vol.37 (8), p.1741-1744

2023

Link zum Volltext

Verfügbarkeit prüfen

Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement

British journal of haematology, 2022-02, Vol.196 (3), p.676-680

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 160

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(155)

Publikationsform

Artikel
(157)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Life Sciences & Biomedicine
(67)
Humans
(60)
Hematology
(49)
Biological And Medical Sciences
(33)
Medical Sciences
(31)
Female
(25)
Male
(25)
Hematologic And Hematopoietic Diseases
(24)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(19)
Mutation
(18)
Animals
(17)
Myeloproliferative Disorders - Genetics
(17)
Janus Kinase 2 - Genetics
(16)
Mice
(16)
Adult
(15)
Biochemistry
(14)
Cell Biology
(14)
Immunology
(14)
Middle Aged
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(85)
British Journal Of Haematology
(10)
Cancer Research
(5)
Haematologica
(4)
Blood Advances
(3)
Journal Of Inherited Metabolic Disease
(3)
Oncogene
(3)
American Journal Of Hematology
(2)
Annales De Biologie Clinique
(2)
Blood Cancer Journal
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases

Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA‐PegIFN study)

Prominent role of TGF-β1 in thrombopoietin-induced myelofibrosis in mice

Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation

Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis

Expression level and differential JAK2-V617F–binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms

Ex Vivo Characterization of Multiepitopic Tumor-Specific CD8 T Cells in Patients with Chronic Myeloid Leukemia: Implications for Vaccine Development and Adoptive Cellular Immunotherapy

Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia

Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study

Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs

Calcific tendinopathy: an unexpected side effect of tyrosine kinase inhibitor?

Insights into the Potential Mechanisms of JAK2V617F Somatic Mutation Contributing Distinct Phenotypes in Myeloproliferative Neoplasms

Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia

Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO

Mechanisms of Thrombocytopenia During Septic Shock: A Multiplex Cluster Analysis of Endogenous Sepsis Mediators

From 1 to 2 mutated JAK2: the road from ET to PV

JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders

High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice

Retinoid-induced activation of NF-κB in APL cells is not essential for granulocytic differentiation, but prolongs the life span of mature cells

Role for the nuclear factor κB pathway in transforming growth factor-β1 production in idiopathic myelofibrosis : Possible relationship with FK506 binding protein 51 overexpression

miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets

Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID)

Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement

Aktive Filter

Suchergebnisse filtern